By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Bristol-Myers Squibb Company 

38 Jackson Road

Devens  Massachusetts  01434  U.S.A.
Phone: n/a Fax: n/a


Bristol-Myers Squibb is a global biopharmaceutical company dedicated to helping patients prevail against serious disease.

We have delivered nine new products to patients in the last seven years for the treatment of psychiatric disorders, cancer, HIV, chronic hepatitis B and rheumatoid arthritis. We anticipate up to 6 additional regulatory approvals or submissions through 2012. In addition, scores of investigational medicines are advancing through our pharmaceutical development pipeline for such additional diseases as diabetes and cardiovascular disease, solid organ transplant rejection, Alzheimer's and obesity.

Bristol-Myers Squibb is recognized as having one of the most productive pipelines in the industry. Two of our marketed productive pipelines in the industry. Two of our marketed medicines and a number of investigational products are biologics. In the fight against serious disease, biologics - or protein-derived therapies - are playing an increasingly prominent role.

In our quest to help patients prevail, we are redefining our company and transforming ourselves for the future. By uniquely combining the strengths of a traditional pharmaceutical company with the attributes of a successful biotech company, we are becoming a new kind of enterprise, a next generation BioPharma. We are focused - agile and flexible, and infused with the entrepreneurial culture of an innovative biotech. Yet, at the same time, we are large enough to marshal the resources necessary to invest in our pipeline and bring new medicines to patients in need.

As a BioPharma leader, we are complementing and enhancing our internal capabilities with innovative alliances, partnerships and acquisitions. We call this our String of Pearls strategy.

Over the years, Bristol-Myers Squibb and its employees have received numerous distinguished awards and recognitions, including the National Medal of Technology and the Lasker Award for Medical Research. Recently, Bristol-Myers Squibb was included among Barron's 2009 Most Respected Companies Survey. Also, we've been hailed year after year as one of the best companies for working mothers and executive women, and as an acknowledged industry leader in environment, health, and safety management.

Key Statistics

Ownership: Public

Web Site: Bristol-Myers Squibb Company
Symbol: BMY

Company News
Bristol-Myers Squibb Company (BMY) To Hold Investor Teleconference To Discuss CMSTO Highlights 10/13/2014 8:28:07 AM
Bristol-Myers Squibb Company (BMY) Sheds $1.4B In Pension Liabilities By Transferring Risk To Prudential 10/1/2014 6:25:21 AM
Bristol-Myers Squibb Company (BMY)'s Immunotherapy Drug Opdivo Gets Six Month FDA Review For Melanoma 9/26/2014 4:17:15 PM
World Heart Federation Announces A Donation From Bristol-Myers Squibb Company (BMY) And Pfizer (PFE) For A Program To Help Improve Experiences For People With Atrial Fibrillation (AF) 9/25/2014 8:45:53 AM
Bristol-Myers Squibb Company (BMY) Will Add New Building, 2,500 Workers In NJ 9/24/2014 10:16:35 AM
Bristol-Myers Squibb Company (BMY) Announces Dividend 9/17/2014 9:52:39 AM
Bristol-Myers Squibb Company (BMY) To Present At Bank of America (BAC) Merrill Lynch Global Health Care Conference 9/11/2014 11:50:15 AM
Bristol-Myers Squibb Company (BMY) To Present At Bank Of America Merrill Lynch Global Health Care Conference 9/11/2014 9:43:33 AM
FDA Approves Use Of Bristol-Myers Squibb Company (BMY), Pfizer Inc. (PFE)'s Eliquis To Treat Leg, Lung Clots 8/21/2014 2:16:10 PM
Allergan Inc. (AGN), Bristol-Myers Squibb Company (BMY) On The Prowl For Space In Crowded Cambridge, Massachusetts 8/19/2014 10:02:02 AM